申联生物 (688098.SH)

今开: 最高: 成交量:

昨收: 最低: 成交额:

+ 收藏

利润表(单季度)(申联生物)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2024年第三季度2024年第二季度2024年第一季度2023年第四季度2023年第三季度2023年第二季度2023年第一季度
上市前/上市后 上市后上市后上市后上市后上市后上市后上市后
报表类型 合并报表合并报表合并报表合并报表合并报表合并报表合并报表
一、营业总收入(元) 121,926,877.9538,317,778.6388,058,162.6762,061,047.11116,354,484.5441,219,696.8181,851,831.18
 营业收入(元) 121,926,877.9538,317,778.6388,058,162.6762,061,047.11116,354,484.5441,219,696.8181,851,831.18
二、营业总成本(元) 96,459,544.9972,985,270.1789,817,686.5872,083,995.8582,540,975.5152,042,394.2663,992,804.57
 营业成本(元) 43,975,486.1418,252,625.4234,322,284.9821,144,067.6030,612,107.3413,633,474.0222,544,394.37
 研发费用(元) 12,135,473.6312,972,509.7212,646,826.2714,268,087.7911,380,013.7810,121,905.608,757,354.77
 营业税金及附加(元) 1,252,033.95960,218.311,109,000.701,067,929.331,150,507.761,204,172.78988,911.58
 销售费用(元) 23,869,977.0427,881,435.4725,474,086.1223,807,481.4526,217,998.9515,939,897.3918,420,235.02
 管理费用(元) 15,433,419.1613,189,807.8716,372,116.7712,015,616.1913,546,856.0611,326,091.6213,441,506.90
 财务费用(元) -206,844.93-271,326.62-106,628.26-219,186.51-366,508.38-183,147.15-159,598.07
  其中:利息收入(元) 220,147.32278,971.85117,223.57226,787.16377,971.84219,586.06160,635.85
 资产减值损失(元) 8,213.8834,450.58-61,074.2336,140.52-6,731.62-725.4211,379.89
 信用减值损失(元) -8,485,909.30-1,120,966.98-2,608,986.753,133,217.88-3,540,656.13-1,200,551.95-1,523,710.84
三、其他经营收益
 加:公允价值变动收益(元) -152,114.8399,261.9216,870.393,272,745.14756,224.04-2,443,245.34766,200.29
 加:投资收益(元) 411,226.56437,137.01569,785.33-4,532,103.46740,922.955,524,757.131,702,512.35
  其中:对联营企业和合营企业的投资收益(元) 4,404.10-9,551.927,026.745,377.74-4,804.588,233.59-20.66
 其他收益(元) 668,232.391,832,996.65347,608.511,036,200.17268,958.78942,958.78346,929.93
四、营业利润(元) 17,916,981.66-33,384,612.36-3,495,320.66-7,076,265.5332,032,227.05-7,999,504.2519,162,338.23
 加:营业外收入(元) 52,769.25--3,496.8012,899.74744,927.000.10
 减:营业外支出(元) 24,129.17277,843.157,129.1628,577.86350,357.60185,055.8151,029.82
五、利润总额(元) 17,945,621.74-33,648,342.45-3,502,449.82-7,101,346.5931,694,769.19-7,439,633.0619,111,308.51
 减:所得税费用(元) -1,469,550.81-338,115.01-377,061.23-467,374.825,142,533.51-1,504,170.453,243,675.91
六、净利润(元) 19,415,172.55-33,310,227.44-3,125,388.59-6,633,971.7726,552,235.68-5,935,462.6115,867,632.60
(一)按经营持续性分类
  持续经营净利润(元) 19,415,172.55-33,310,227.44-3,125,388.59-6,633,971.7726,552,235.68-5,935,462.6115,867,632.60
(二)按所有权归属分类
  归属于母公司股东的净利润(元) 20,383,291.92-32,298,788.59-2,209,184.73-5,605,619.3427,192,127.78-5,935,462.6115,867,632.60
  少数股东损益(元) -968,119.37-1,011,438.85-916,203.86-1,028,352.43---
 扣除非经常性损益后的净利润(元) 19,902,297.27-32,574,791.93-2,869,254.06-4,625,581.1026,002,876.50-9,825,154.5613,517,692.00
七、每股收益
 一、基本每股收益(元) 0.05-0.07-0.01-0.010.07-0.020.04
 二、稀释每股收益(元) 0.05-0.07-0.01-0.010.07-0.020.04
九、综合收益总额(元) 19,415,172.55-33,310,227.44-3,125,388.59-6,633,971.7726,552,235.68-5,935,462.6115,867,632.60
 归属于母公司所有者的综合收益总额(元) 20,383,291.92-32,298,788.59-2,209,184.73-5,605,619.3427,192,127.78-5,935,462.6115,867,632.60
 归属于少数股东的综合收益总额(元) -968,119.37-1,011,438.85-916,203.86-1,028,352.43---
公告日期 2024-10-312024-08-302024-04-272024-04-272023-10-312023-08-302023-04-27
审计意见(境内) 标准无保留意见

前瞻产业研究院